Your search for "deferral" matched 135 page(s).
Showing results 21 to 30.
For the early benefit assessment of new drugs in Germany, medical writers are involved in the preparation of dossiers submitted by pharmaceutical companies to the main decision-making body of the German statutory healthcare system, the Federal Joint…
The early benefit assessment of new drugs was introduced in Germany in 2011. The main rationale was to support pricing negotiations between the statutory health insurance (SHI) system and the pharmaceutical industry. The early benefit assessment…
The hijacking of peer review by authors who create false referee profiles in order to deliver favourable reviews of their own work has received prominent recent coverage in several leading journals. At the time of writing, over 300 articles had been…
In this article, I provide a checklist of eight items to improve your writing. Several of the checklist items are discussed in detail in other articles in this issue of Medical Writing, although I provide explanations and examples for each item. I…
After several lockdowns, “everyday” life is beginning to return, although COVID-19 continues to be a destructive force in many parts of the world. In Germany, where I am currently located, COVID-19 cases have been rather low (with occasional…
For the last 6 years, James Visanji has volunteered as EMWA’s Treasurer and as a member of the Executive Committee. James stepped down from this role at the conference in Vienna this past May, so several of us on the Executive Committee wanted to…
In September 2021, the editors-in-chief of over 200 biomedical and scientific journals from all geographic regions issued a call for Emergency Action to Limit Global Temperature Increases, Restore Biodiversity, and Protect Health.1 This editorial…
For this Webscout, I decided to leave the path of scientific writing and enter the land of marketing, which goes overall with the theme of post-approval medical writing. However, I will not limit this Webscout to medical marketing and instead take a…
The good news first: Patient-reported outcomes (PRO) are basically the same in both the medical device and the pharmaceutical sectors. There are the general quality of life tools such as the EQ-5D or the Short-Form Survey questionnaires (e.g. SF-12,…
The 6th EMWA symposium day will focus on medical devices in general, the recent changes in the European legislations, and opportu - nities for medical writers. The symposium is for regulatory writers and medical communi - cators alike, and will…
Medical Writing is a quarterly publication that aims to educate and inform medical writers in Europe and beyond. Each issue focuses on a specific theme, and all issues include feature articles and regular columns on topics relevant to the practice of medical writing. We welcome articles providing practical advice to medical writers; guidelines and reviews/summaries/updates of guidelines published elsewhere; original research; opinion pieces; interviews; and review articles.
Medical Writing is listed in the following indexes:
Editor-in-Chief
Co-Editors
Senior Editor
Victoria White
Managing Editor
Alicia Brooks Waltman
Associate Editors
Section Editors
AI/Automation
Biotechnology
Digital Communication
EMWA News
Freelancing
Gained in Translation
Getting Your Foot in the Door
Good Writing Practice
Pablo Izquierdo / Alison McIntosh
In the Bookstores
Publications
Medical Communications/Writing for Patients
Medical Devices
My First Medical Writing
News from the EMA
Pharmacovigilance
Regulatory Matters
Regulatory Public Disclosure
Louisa Ludwig-Begall / Sarah Kabani
The Crofter: Sustainable Communications
Veterinary Writing
Editors Emeritus
Layout Designer
Chris Monk